Actavia Life Sciences, Inc.
RASP · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Market Cap | $12 | $1 | $4 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $1 | $1 |
| Enterprise Value | $12 | $1 | $5 | $6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | $0 | -$0 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$4 | -$1 | -$1 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.008 | -0.006 | -0.013 | -0.078 |
| % Growth | -24.2% | 51.2% | 83.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |